July 6, 2021 How a CDMO alliance sets new standards for drug development and commercialization

Interview with our business development experts in Labiotech

Our strategic collaboration with Vetter to simplify and speed up drug development and commercialization for our clients has been consistently growing from strength to strength since mid-2020.

While Rentschler Biopharma specializes in drug substance manufacturing, including bioprocess development as well as clinical and commercial production, Vetter has long-standing experience in drug product manufacturing, including process design, as well as clinical and commercial fill and finish.

Patrick Meyer and John Moore, our colleagues from business development, spoke to Labiotech, a leading online media for the biotech industry in Europe about how together, we are setting new standards to facilitate project coordination for our clients.

Please follow this link to read the entire interview here. To learn more about our client offerings, please click here.